AFJK Stock Overview
Aimei Health Technology Co., Ltd does not have significant operations.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Aimei Health Technology Co., Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$10.27 |
| 52 Week High | US$10.30 |
| 52 Week Low | US$10.15 |
| Beta | 0 |
| 1 Month Change | 0.14% |
| 3 Month Change | 1.03% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 1.23% |
Recent News & Updates
Recent updates
Shareholder Returns
| AFJK | US Capital Markets | US Market | |
|---|---|---|---|
| 7D | 0.04% | -1.8% | -0.7% |
| 1Y | n/a | 31.5% | 22.8% |
Return vs Industry: Insufficient data to determine how AFJK performed against the US Capital Markets industry.
Return vs Market: Insufficient data to determine how AFJK performed against the US Market.
Price Volatility
| AFJK volatility | |
|---|---|
| AFJK Average Weekly Movement | 0.3% |
| Capital Markets Industry Average Movement | 3.4% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: AFJK has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine AFJK's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2023 | n/a | Juan Pascual | n/a |
Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.
Aimei Health Technology Co., Ltd Fundamentals Summary
| AFJK fundamental statistics | |
|---|---|
| Market cap | US$92.61m |
| Earnings (TTM) | US$257.08k |
| Revenue (TTM) | n/a |
360.7x
P/E Ratio0.0x
P/S RatioIs AFJK overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AFJK income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | -US$257.08k |
| Earnings | US$257.08k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.028 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0% |
How did AFJK perform over the long term?
See historical performance and comparison